Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort
about
AMPK: An emerging target for modification of injury-induced pain plasticity.Schwann cell interactions with axons and microvessels in diabetic neuropathy.Diabetic Polyneuropathy in Type 2 Diabetes Mellitus: Inflammation, Oxidative Stress, and Mitochondrial Function.Adenosine Monophosphate-activated Protein Kinase (AMPK) Activators For the Prevention, Treatment and Potential Reversal of Pathological Pain.Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes.Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K.The influence of autonomic dysfunction associated with aging and type 2 diabetes on daily life activities.Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes.Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in Type 1 diabetes: results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications.Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Cohort.The use of metformin is associated with decreased lumbar radiculopathy pain.Peripheral and Autonomic Neuropathy in South Asians and White Caucasians with Type 2 Diabetes Mellitus: Possible Explanations for Epidemiological Differences.Mechanism of diabetic neuropathy: Where are we now and where to go?Exercise as Therapy for Diabetic and Prediabetic Neuropathy.Potential of Dietary Non-Provitamin A Carotenoids in the Prevention and Treatment of Diabetic Microvascular Complications.Targeting AMPK for the Alleviation of Pathological Pain.Prevalence of diabetic neuropathy in patients undergoing foot and ankle surgery.Alterations in circulating angiogenic and anti-angiogenic factors in type 2 diabetic patients with neuropathy.Physical Exercise Improves Heart Rate Variability in Patients with Type 2 Diabetes: A Systematic Review.Effects of metformin on the expression of AMPK and STAT3 in the spinal dorsal horn of rats with neuropathic pain.Three-question set from Michigan Neuropathy Screening Instrument adds independent prognostic information on cardiovascular outcomes: analysis of ALTITUDE trial.The prevalence and risk factors of peripheral neuropathy among patients with type 2 diabetes mellitus; the case of Jordan.Community based study to assess the prevalence of diabetic foot syndrome and associated risk factors among people with diabetes mellitus.
P2860
Q27021903-11D06941-C562-4B3D-9A44-2F3C9D6433ECQ30238727-97EA17B9-1F96-46A9-ABAF-6116DD8FD7D6Q30239828-7FF896BD-1240-47F7-ACCC-A5C59994E38FQ30383901-E9348812-AFE9-4B18-AB5C-6DFA5A777AC5Q34762475-1E1D3191-9EC0-415B-A965-F39DE81DCD07Q35225448-85EAEED7-AD79-4B4E-9460-1A7DDEBE6823Q35903671-BFB6C4AC-C91D-4509-A996-BB8F32871F3FQ35976587-0F5D1789-CE67-4A8E-AFE4-2F5EFB371661Q36810364-4AC4E6CA-6EB8-4C9F-912C-7AE3AA5697B2Q37193699-D04DF4AC-A7C4-4AE4-B08B-BF193C5020A1Q37391076-8C243B55-254B-4E1A-B0D2-6980DC837CD7Q37734331-311878AB-C233-4BA4-AAE7-59019D0D88F4Q38213041-B65FE8A3-7B03-49BE-B882-04FB9CFCA73BQ38625575-F217B47D-014E-4BA1-9F31-83722E1B9D0AQ38698313-CCFE2CA9-CEBB-451F-8DEC-E3CB16CAEF16Q38998418-0FFB48E6-BE09-4617-BC28-4083B52BF4F6Q43810053-64980C2D-109F-4239-87CD-CB029208935AQ47862770-77075DF0-9A51-4253-BD7F-4BCBBB431927Q47932887-1D7AF70F-831C-42EE-99D0-5B39C31C0E90Q49378684-D2C7225D-4FCB-423D-BCEA-E30018D9E749Q53091549-853704FA-9A7E-447C-850E-C2229C3F5C35Q55237417-7FC999D7-3362-4FAA-97C7-81990ABCB909Q55462870-F1A304AC-01CB-4ADD-9A2C-5CB8D4DAD9A4
P2860
Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prevalence of diabetic periphe ...... baseline in the BARI 2D cohort
@ast
Prevalence of diabetic periphe ...... baseline in the BARI 2D cohort
@en
type
label
Prevalence of diabetic periphe ...... baseline in the BARI 2D cohort
@ast
Prevalence of diabetic periphe ...... baseline in the BARI 2D cohort
@en
prefLabel
Prevalence of diabetic periphe ...... baseline in the BARI 2D cohort
@ast
Prevalence of diabetic periphe ...... baseline in the BARI 2D cohort
@en
P2093
P2860
P1476
Prevalence of diabetic periphe ...... baseline in the BARI 2D cohort
@en
P2093
BARI 2D Investigators
Neuza Lopes
Teresa L Z Jones
P2860
P356
10.1111/J.1529-8027.2009.00200.X
P577
2009-03-01T00:00:00Z